{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:48:22Z","timestamp":1793400502464,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.tmrv.2013.05.005","type":"journal-article","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T21:15:34Z","timestamp":1373318134000},"page":"137-145","source":"Crossref","is-referenced-by-count":163,"title":["Approach to the Diagnosis and Management of Drug-Induced Immune Thrombocytopenia"],"prefix":"10.1016","volume":"27","author":[{"given":"Donald M.","family":"Arnold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishac","family":"Nazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore E.","family":"Warkentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Toltl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Kelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2013.05.005_bb0005","first-page":"519","article-title":"Occult quinine-induced thrombocytopenia","volume":"93","author":"Kojouri","year":"2000","journal-title":"J Okla State Med Assoc"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0010","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1365-2141.2003.04547.x","article-title":"Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients","volume":"122","author":"Neylon","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0015","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1538-7836.2009.03360.x","article-title":"Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management","volume":"7","author":"Aster","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0020","series-title":"Hematology: basic principles and practice","first-page":"1895","article-title":"Thrombocytopenia caused by platelet destruction, hypersplenism, or hemodilution","author":"Warkentin","year":"2013"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/jth.12052","article-title":"A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia","volume":"11","author":"Arnold","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1592\/phco.20.4.292.34883","article-title":"Evaluation and management of drug-induced thrombocytopenia in the acutely ill patient","volume":"20","author":"Wazny","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0040","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/AAC.46.8.2723-2726.2002","article-title":"Hematologic effects of linezolid: summary of clinical experience","volume":"46","author":"Gerson","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0045","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1086\/338403","article-title":"Thrombocytopenia associated with linezolid therapy","volume":"34","author":"Attassi","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0050","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1097\/CCM.0b013e3181de0b88","article-title":"Drug-induced thrombocytopenia in critically ill patients","volume":"38","author":"Priziola","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/00365548.2011.608712","article-title":"Correlation between serum linezolid concentration and the development of thrombocytopenia","volume":"44","author":"Hiraki","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0060","first-page":"2615","article-title":"Proteasome inhibitors: a novel class of potent and effective antitumor agents","volume":"59","author":"Adams","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0065","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1182\/blood-2005-03-1173","article-title":"Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma","volume":"106","author":"Lonial","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0070","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1600-0609.2010.01415.x","article-title":"Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages","volume":"84","author":"Royer","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0075","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ajh.10148","article-title":"Spontaneous reports of thrombocytopenia in association with quinine: clinical attributes and timing related to regulatory action","volume":"70","author":"Brinker","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0080","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/asheducation-2006.1.408","article-title":"Think of HIT","author":"Warkentin","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0085","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra066469","article-title":"Drug-induced immune thrombocytopenia","volume":"357","author":"Aster","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0090","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1146\/annurev.bi.60.070191.004051","article-title":"Denatured states of proteins","volume":"60","author":"Dill","year":"1991","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0095","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1182\/blood-2009-09-242297","article-title":"A hypothesis that explains the heterogeneity of drug-induced immune thrombocytopenia","volume":"115","author":"Li","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0300-483X(95)03253-C","article-title":"T cell immune responses to haptens. Structural models for allergic and autoimmune reactions","volume":"107","author":"Weltzien","year":"1996","journal-title":"Toxicology"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0887-7963(93)70145-5","article-title":"Immune cytopenia associated with antibiotics","volume":"7","author":"Garratty","year":"1993","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1537-2995.1984.24585017827.x","article-title":"Red cell and platelet-bound IgG penicillin antibodies in a patient with thrombocytopenia","volume":"24","author":"Salamon","year":"1984","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0115","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.1378\/chest.127.2_suppl.53S","article-title":"Immune thrombocytopenia caused by glycoprotein IIb\/IIIa inhibitors","volume":"127","author":"Aster","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0120","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1182\/blood.V100.6.2071","article-title":"Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb\/IIIa","volume":"100","author":"Bougie","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0125","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1172\/JCI36745","article-title":"Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain","volume":"119","author":"Gao","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0130","doi-asserted-by":"crossref","first-page":"13114","DOI":"10.1073\/pnas.0404201101","article-title":"Integrin beta3 regions controlling binding of murine mAb 7E3: implications for the mechanism of integrin alphaIIbbeta3 activation","volume":"101","author":"Artoni","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0135","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","article-title":"Investigation. Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty","volume":"330","author":"The","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0140","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.amjcard.2003.12.051","article-title":"Final results of the ReoPro readministration registry","volume":"93","author":"Dery","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0145","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1182\/blood.V99.6.2054","article-title":"Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets","volume":"99","author":"Curtis","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-146-1-200701020-00006","article-title":"Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura","volume":"146","author":"Arnold","year":"2007","journal-title":"Ann Intern Med"},{"issue":"Suppl","key":"10.1016\/j.tmrv.2013.05.005_bb0155","first-page":"ECR23","article-title":"Rituximab-induced acute thrombocytopenia: a report of two cases","volume":"90","author":"Otrock","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2141.2006.06299.x","article-title":"Rituximab-induced haemorrhagic thrombocytopenia in a patient with hairy cell leukaemia","volume":"135","author":"Thachil","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ajh.21372","article-title":"Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon","volume":"84","author":"Ram","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ajh.20218","article-title":"Rituximab-induced acute thrombocytopenia in a patient with prolymphocytic leukemia","volume":"78","author":"Pamuk","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0175","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1182\/blood-2011-08-371138","article-title":"A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis","volume":"118","author":"Cuker","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0180","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood.V84.11.3691.bloodjournal84113691","article-title":"Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia","volume":"84","author":"Warkentin","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0185","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1046\/j.1365-2141.1996.d01-1944.x","article-title":"A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry","volume":"95","author":"Lee","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0190","doi-asserted-by":"crossref","DOI":"10.1111\/trf.12112","article-title":"Protamine-induced immune thrombocytopenia","author":"Singla","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0195","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2012-10-460691","article-title":"Anti-protamine-heparin antibodies: incidence, clinical relevance and pathogenesis","volume":"121","author":"Bakchoul","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0200","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood-2012-11-469130","article-title":"High incidence of antibodies to protamine and protamine\/heparin complexes in patients undergoing cardiopulmonary bypass","volume":"121","author":"Lee","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0205","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMp068309","article-title":"Drug-induced immune-mediated thrombocytopenia\u2014from purpura to thrombosis","volume":"356","author":"Warkentin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0210","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1182\/blood-2009-02-203034","article-title":"Megakaryocyte impairment by eptifibatide-induced antibodies causes prolonged thrombocytopenia","volume":"114","author":"Greinacher","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0215","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1182\/blood-2010-10-314310","article-title":"Quinine-induced thrombocytopenia: drug-dependent GPIb\/IX antibodies inhibit megakaryocyte and proplatelet production in vitro","volume":"117","author":"Perdomo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0220","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archinte.164.2.218","article-title":"Quinine\/quinidine-induced thrombocytopenia: a great imitator","volume":"164","author":"Reddy","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0225","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/ajh.20916","article-title":"Immune thrombocytopenia from vancomycin in orthopedic cement","volume":"82","author":"O'Donnell","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0230","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(11)61643-7","article-title":"Thrombocytopenia in a nutshell","volume":"379","author":"Achterbergh","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0235","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00009","article-title":"Drug-induced thrombocytopenia: a systematic review of published case reports","volume":"129","author":"George","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0240","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1538-7836.2004.00744.x","article-title":"Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug","volume":"2","author":"Curtis","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0245","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-2007-1005047","article-title":"Drug-induced platelet destruction","volume":"8","author":"Hackett","year":"1982","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0250","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood-2010-03-276691","article-title":"Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods","volume":"116","author":"Reese","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0255","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa065066","article-title":"Vancomycin-induced immune thrombocytopenia","volume":"356","author":"Von","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.21307\/immunohematology-2019-245","article-title":"Detection and identification of platelet antibodies and antigens in the clinical laboratory","volume":"25","author":"Curtis","year":"2009","journal-title":"Immunohematology"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0265","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/0002-9343(56)90164-4","article-title":"Hemolytic anemia due to quinidine: observations on its mechanism","volume":"20","author":"Freedman","year":"1956","journal-title":"Am J Med"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0270","first-page":"272","article-title":"The development and application of a serum assay for platelet-bindable IgG (S-PBIgG)","volume":"98","author":"Kelton","year":"1981","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0275","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1537-2995.1965.tb01182.x","article-title":"Change in platelet factor 3 as a means of demonstrating immune reactions involving platelets: Its use as a test for Quinidine-induced thrombocytopenia","volume":"5","author":"Horowitz","year":"1965","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0280","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V33.6.795.795","article-title":"In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus","volume":"33","author":"Karpatkin","year":"1969","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0285","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00000441-197402000-00008","article-title":"Aspirin-induced thrombocytopenia on an immune basis","volume":"267","author":"Garg","year":"1974","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0290","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0002-9343(66)90222-1","article-title":"Thrombocytopenia due to digitoxin. Demonstration of antibody and mechanisms of action","volume":"41","author":"Young","year":"1966","journal-title":"Am J Med"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0295","first-page":"161","article-title":"Simplified complement fixation test for the detection of platelet antibodies in human serum","volume":"63","author":"Aster","year":"1964","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0300","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1001\/jama.239.24.2586","article-title":"Sulfisoxazole-induced thrombocytopenic purpura. Immunologic mechanism as cause","volume":"239","author":"Hamilton","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0305","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1172\/JCI106084","article-title":"A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies","volume":"48","author":"Aster","year":"1969","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0310","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ajh.2830020109","article-title":"Detection of drug-dependent antibodies by the 51Cr platelet lysis test: documentation of immune thrombocytopenia induced by diphenylhydantoin, diazepam, and sulfisoxazole","volume":"2","author":"Cimo","year":"1977","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0315","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1182\/blood.V97.12.3846","article-title":"Immune thrombocytopenia resulting from sensitivity to metabolites of naproxen and acetaminophen","volume":"97","author":"Bougie","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0320","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1182\/asheducation-2009.1.153","article-title":"Drug-induced thrombocytopenia: pathogenesis, evaluation, and management","author":"George","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.tmrv.2013.05.005_bb0325","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1423-0410.2010.01348.x","article-title":"Report on the 14th International Society of Blood Transfusion Platelet Immunology Workshop","volume":"99","author":"Wu","year":"2010","journal-title":"Vox Sang"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796313000382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796313000382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T15:25:38Z","timestamp":1645975538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796313000382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0887796313000382"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2013.05.005","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}